Flipkart, Amazon, and Snapdeal penalised for selling medicines

The Maharashtra government has taken action against e-commerce giants Snapdeal, Amazon and Flipkart which were selling medicines online without valid licences. Food and Drug Administration, Maharashtra has taken regulatory action against these three companies, which were found to be selling or distributing medicines to consumers through internet without valid sales bill and requisite licenses. In accordance with provisions of the Drugs and Cosmetics Act, 1940 and Rules, the sale of drugs in the country is regulated by state licencing authorities.

Accordingly, drugs specified in Schedule H, H1 or Schedule X cannot be sold except on and in accordance with the prescription of a registered medical practitioner. The supply of prescription drugs can be effected only by or under the personal supervision of a registered pharmacist from a licenced premises.

Health Minister Nadda said there is no proposal of the government to amend the Drug and Cosmetic Act to enable easy facilitation of business in the drug e-commerce sector.